The scientist’s investigation covers issues in Pathology, Prostate cancer, Cancer, Internal medicine and Oncology. His Pathology research is multidisciplinary, relying on both Biomarker, Cirrhosis, Classifier and Immunoassay. O. John Semmes has included themes like Molecular biology, Biopsy, Prostate and Protein kinase A in his Prostate cancer study.
O. John Semmes has researched Cancer in several fields, including Blood test, Signal transduction, Mass spectrometry imaging, Kinase and MAP kinase kinase kinase. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Proteomic Profiling. The Oncology study combines topics in areas such as Case-control study, Carcinoma, Blood plasma, Serum protein and Breast cancer.
His scientific interests lie mostly in Prostate cancer, Molecular biology, Proteomics, Pathology and Cancer. O. John Semmes combines subjects such as Cancer cell and Prostate with his study of Prostate cancer. His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Cytoplasm, Phosphorylation, Cell biology and Mutant.
His Proteomics research includes themes of Proteome, Bioinformatics, Computational biology and Mass spectrometry. His Pathology study combines topics in areas such as Head and neck squamous-cell carcinoma, Serum protein, Gel electrophoresis and Early detection. The Cancer study which covers Oncology that intersects with Disease.
O. John Semmes focuses on Prostate, Prostate cancer, Proteome, Cancer research and Microvesicles. His work deals with themes such as Biochemistry, Quantitative proteomics and Bioinformatics, which intersect with Prostate. His biological study spans a wide range of topics, including Liquid biopsy and Personalized medicine.
In his research on the topic of Proteome, Metabolomics and Computational biology is strongly related with Biomarker discovery. His Microvesicles research integrates issues from Biomarker, T-cell leukemia and Antibody, Immunology. As part of his studies on Cancer, O. John Semmes frequently links adjacent subjects like Proteomics.
His primary areas of investigation include Proteome, Prostate, Prostate cancer, Biochemistry and Exosome. The concepts of his Proteome study are interwoven with issues in Proteomics, Quantitative proteomics, Liquid biopsy, Personalized medicine and Extraprostatic. His research ties Bioinformatics and Prostate together.
His work on Amino acid, Mutagenesis, Mutant and Alanine as part of general Biochemistry study is frequently linked to SAMHD1, bridging the gap between disciplines. His Exosome research incorporates elements of Immunology, Shotgun proteomics and Biomarker discovery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men
Bao Ling Adam;Yinsheng Qu;John W. Davis;Michael D. Ward.
Cancer Research (2002)
Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients
Yinsheng Qu;Bao Ling Adam;Yutaka Yasui;Michael D. Ward.
Clinical Chemistry (2002)
Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility
O. John Semmes;Ziding Feng;Bao Ling Adam;Lionel L. Banez.
Clinical Chemistry (2005)
Clinical proteomics: A need to define the field and to begin to set adequate standards.
Harald Mischak;Rolf Apweiler;Rosamonde E. Banks;Mark Conaway.
Proteomics Clinical Applications (2007)
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak;Guenter Allmaier;Rolf Apweiler;Teresa Attwood.
Science Translational Medicine (2010)
Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers
Richard R. Drake;E. Ellen Schwegler;Gunjan Malik;Jose Diaz.
Molecular & Cellular Proteomics (2006)
Tissue Imaging Using Nanospray Desorption Electrospray Ionization Mass Spectrometry
Julia Laskin;Brandi S. Heath;Patrick J. Roach;Lisa H. Cazares.
Analytical Chemistry (2012)
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
Lisa H. Cazares;Bao-Ling Adam;Michael D. Ward;Suhail Nasim.
Clinical Cancer Research (2002)
Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue
Lisa H. Cazares;Dean Troyer;Savvas Mendrinos;Raymond A. Lance.
Clinical Cancer Research (2009)
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
E. Ellen Schwegler;Lisa Cazares;Laura F. Steel;Bao Ling Adam.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: